JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120829

CyPPA, SK channel activator

Be the first to review this product! Submit a review

|

(0 Publication)

MW 285.39 g/mol, Purity >98%. First selective small conductance Ca2+-activated K+ channel (SK) activator. Selectively opens SK2 and SK3 channels (EC50 values are 5.6 and 14 μM, respectively). Shows no activity at SK1 and IK. Additionally reduces activity and excitability of dopamine neurons. Active in vivo.
1 Images
Chemical Structure - CyPPA, SK channel activator (AB120829)
  • Chemical Structure

Lab

Chemical Structure - CyPPA, SK channel activator (AB120829)

2D chemical structure image of ab120829, CyPPA, SK channel activator

Key facts

CAS number

73029-73-9

Purity

>98%

Form

Solid

form

Molecular weight

285.39 g/mol

Molecular formula

C<sub>1</sub><sub>6</sub>H<sub>2</sub><sub>3</sub>N<sub>5</sub>

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Soluble in ethanol to 100 mM

Biological description

First selective small conductance Ca2+-activated K+ channel (SK) activator. Selectively opens SK2 and SK3 channels (EC50 values are 5.6 and 14 μM, respectively). Shows no activity at SK1 and IK. Additionally reduces activity and excitability of dopamine neurons. Active in vivo.

IUPAC Name

N-Cyclohexyl-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methyl-4-pyrimidinamine

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com